69 results
6-K
EX-10.1
NNOX
Nano X Imaging Ltd
7 Jun 24
Report of Foreign Private Issuer
5:21pm
a Material Adverse Effect.
(ff) Israeli Tax Benefits. Except for the rulings dated February 8, 2022 and August 30, 2022 received by the Company from … Enterprise” status or benefits (collectively, “Tax Incentive Program”), and by Israeli laws and regulations has not made any claims for tax benefits
424B5
NNOX
Nano X Imaging Ltd
7 Jun 24
Prospectus supplement for primary offering
5:06pm
of companies that we acquire and to realize the anticipated benefits of the acquisitions, which may be affected by, among other things, competition … regarding collaborations with third-parties and their potential benefits;
our ability to enter into and maintain our arrangements with third-party
6-K
EX-99.1
NNOX
Nano X Imaging Ltd
28 May 24
Nanox Announces First Quarter of 2024 Financial Results and Provides Business Update
8:10am
technology and the Nanox.ARC, the ability to realize the expected benefits of its recent acquisitions and the projected business prospects … the anticipated benefits of acquisitions, which may be affected by, among other things, competition, brand recognition, the ability of the acquired
6-K
EX-99.1
NNOX
Nano X Imaging Ltd
8 May 24
Report of Foreign Private Issuer
4:01pm
of employment arrangements and other benefits. The cash bonuses that may be granted under the Proposed Compensation Policy are limited to a maximum amount linked … of the relevant executive officer.
Under the Proposed Compensation Policy our executive officers may be granted with several cash and equity benefits upon
POS AM
NNOX
Nano X Imaging Ltd
22 Apr 24
Prospectus update (post-effective amendment)
9:32am
analysis of the U.S. market by clinicians, imaging administrators and directors, stakeholders recognize the clinical benefits of the Nanox System and its … to successfully integrate the business of companies that we acquire and to realize the anticipated benefits of the acquisitions, which may be affected
POSASR
498l9
22 Apr 24
Automatic shelf registration (post-effective amendment)
9:20am
POSASR
EX-4.8
tjjgjrarj
22 Apr 24
Automatic shelf registration (post-effective amendment)
9:20am
6-K
EX-99.1
pnuqg
1 Apr 24
Nanox Announces Fourth Quarter of 2023 Financial Results and Provides Business Update
8:06am
6-K
EX-99.1
cuvqmzg5cg0exap5dzxh
13 Feb 24
Nanox Receives FDA Clearance for HealthFLD, an Advanced AI-Based Software Empowering Clinicians in Assessment of Fatty Liver
8:10am
6-K
EX-99.1
5v6fe6h
16 Jan 24
Nanox Mourns Death of Its Founder, Ran Poliakine
8:35am
6-K
EX-99.1
1os5t16d1wus7yc8f
28 Nov 23
Nanox Announces Third Quarter of 2023 Financial Results and Provides Business Update
8:20am
6-K
EX-99.1
idnddwo w778uk939iw
3 Oct 23
Nanox Announces Strategic Manufacturing Agreement with Varex Imaging Corporation to Advance the Nanox.ARC Medical Imaging System
8:35am
6-K
EX-99.1
ot2iw8va78 02i
17 Aug 23
Nanox Announces Second Quarter of 2023 Financial Results and Provides Business Update
8:05am
6-K
EX-4.1
g3r5ujz67vjo ku
26 Jul 23
Report of Foreign Private Issuer
5:15pm
6-K
EX-4.2
sqoi8x
26 Jul 23
Report of Foreign Private Issuer
5:15pm
424B5
flg2 8g7a
26 Jul 23
Prospectus supplement for primary offering
9:06am
POSASR
pdnbcv073
26 Jul 23
Automatic shelf registration (post-effective amendment)
8:31am
6-K
2kas5yha
24 Jul 23
Nanox Announces $30 Million Registered Direct Offering
8:35am